Bioregulator Peptides: The Emerging Longevity Research Market
Twelve years covering orthopedics and aesthetic medicine teaches you one thing fast: every few years, a raw material class captures the research world's collective attention before the quality control catches up. We saw it with early hyaluronic acid cross-linking variations. We saw it with platelet-rich plasma processing kits before standardization took hold. Right now, in preclinical laboratory settings, short-chain bioregulator peptides are in that exact spot. Venture capital
Continue Reading